Loading
Loading…
Loading…
| # | Company | Offered Item | Status |
|---|---|---|---|
| 1 | Not yet disclosed by govt. Qualified Make: Contrast
Model: GADOTERATE MEGLUMINE INJECTION
Title: Inj Gadoterate Meglumine 0.5 mmol/ml vial of 10 ml | Make: Contrast
Model: GADOTERATE MEGLUMINE INJECTION
Title: Inj Gadoterate Meglumine 0.5 mmol/ml vial of 10 ml | Qualified |
| 2 | M/S ALLEX MEDICAL SYSTEMLikely winner 534 SECTOR 20A CHANDIGARH CHANDIGARH 160020 | CHANDIGARH | CHANDIGARH | 160020 | - | - |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
18 Sept 2025, 5:00 pmClosed
Non ionic contrast medium (0.5 mm ol/ml) for MRI inj Gadoliamide 10 ml Prefilled syringes
Inj Gadoterate Meglumine 0.5 mmol/ml vial of 10 ml
8272995
GEM/2025/B/6614848
Two Packet Bid
Non ionic contrast medium (0.5 mm ol/ml) for MRI inj
28 days
Punjab; Jalandhar
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
80%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| Non ionic contrast medium (0.5 mm ol/ml) for MRI inj Gadoliamide 10 ml Prefilled syringes | JALANDHAR CITY | 20 | 28 days | - |
| Inj Gadoterate Meglumine 0.5 mmol/ml vial of 10 ml | JALANDHAR CITY | 15 | 28 days |
Exempted
25 Sept 2025
28 Aug 2025
18 Sept 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8272995.pdf
GEM_BID
doc_pic_2025-08-25-14-55-58_587cac12357c4b298b5af63fb9a3a151.pdf
SPECIFICATION
doc_pic_2025-08-25-15-00-28_ed1db98e59366b003e04f17f9e3c5e90.pdf
SPECIFICATION
ATC_7efb4737-15e8-42f2-8fa31756378983206_LP_MHJRC.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .